Open Access. Powered by Scholars. Published by Universities.®

Medicine and Health Sciences Commons

Open Access. Powered by Scholars. Published by Universities.®

Philadelphia College of Osteopathic Medicine

2022

Cardiovascular disease

Articles 1 - 2 of 2

Full-Text Articles in Medicine and Health Sciences

Case Report: Abdominal Aortic Aneurysm, Aishwarya Reddy, Jeffry Rima, Nick Morey, Jalisa Jones, Connor Lambert, Shiv Dhiman, S Arya May 2022

Case Report: Abdominal Aortic Aneurysm, Aishwarya Reddy, Jeffry Rima, Nick Morey, Jalisa Jones, Connor Lambert, Shiv Dhiman, S Arya

Research Day

Many research studies have demonstrated that age is a primary risk factor for the prevalence of diseases within developed countries, most notably concerning cardiovascular disease, which has been found to be the leading cause of death globally. Among the diseases that fall beneath this umbrella term of cardiovascular disease, aortic aneurysms (AA) and cerebrovascular accident (CVA; i.e. stroke) are two of the more prevalent and well-known diseases that are identified among the elderly population. However, despite the increasing prevalence of both AAs and CVAs within the elderly in tandem with their shared risk factors - hypertension, smoking, hyperlipidemia, etc. - …


Assessing The Safety And Efficacy Of Finerenone In Patients With Chronic Kidney Disease (Ckd) And Comorbid Type Ii Diabetes (T2d), A Systematic Review, Barry Brown May 2022

Assessing The Safety And Efficacy Of Finerenone In Patients With Chronic Kidney Disease (Ckd) And Comorbid Type Ii Diabetes (T2d), A Systematic Review, Barry Brown

Research Day

Introduction: Potassium-sparing diuretics have long since held an important place in clinical practice; though, there are only a handful of options available. A novel potassium sparing diuretic, finerenone, has recently been investigated in patients with CKD with concomitant T2D to determine its safety and efficacy in a larger group of patients.

Objectives: The purpose of this abstract is to identify and analyze phase III trial data of novel diuretic therapies in patients with CKD and comorbid T2D.

Methods: The terms, “chronic kidney disease”, “type 2 diabetes”, “new therapy”, “effect”, “renal function”, and “cardiovascular disease”, were utilized to conduct a systematic …